The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
about
The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients.Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patientsPlatelet Distribution Width and Serum Albumin Levels for Discrimination of Thyroid Cancer From Benign Thyroid NodulesPrognostic Role of the Pretreatment C-Reactive Protein/Albumin Ratio in Solid Cancers: A Meta-Analysis.Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer.Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.The role of the neutrophil:lymphocyte ratio (NLR) and the CRP:albumin ratio (CAR) in predicting mortality following emergency laparotomy in the over 80 age group.Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma.Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis.Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.
P2860
Q33624392-B9A4F042-7F28-4F75-85EC-2FE9B2D2C8BFQ33774197-6AF268F4-6B44-4051-A9D2-675960C189F1Q38658082-E0A496B8-844F-433B-85A1-7071DB336060Q38995892-70ED0932-8BFA-4A66-A74F-7CEC69CDA13AQ39250764-1E2D1923-1636-49B4-A338-60572C032583Q41016068-E145D4FF-5C1E-4E30-8CE3-166BE5D37977Q42634332-826372FB-F15F-47CC-961B-52C391285E81Q46045146-5A12CF15-E60E-4D78-A2F3-504BD3A6BA32Q48311204-4582938F-D2A0-416C-BB7A-828D6113BF5EQ49712241-47F65AEC-351B-4FE8-AC82-3D33394F2E72Q52576032-0816860C-B71E-49FA-8ECD-A434226D26B9Q52641570-A3651BB3-7426-4DA3-93E2-B43FD6EEE8C2Q55441827-EF3C90F3-88A5-459F-89A1-CCA4DD300EB3
P2860
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The C-reactive protein/albumin ...... th advanced pancreatic cancer.
@en
The C-reactive protein/albumin ...... th advanced pancreatic cancer.
@nl
type
label
The C-reactive protein/albumin ...... th advanced pancreatic cancer.
@en
The C-reactive protein/albumin ...... th advanced pancreatic cancer.
@nl
prefLabel
The C-reactive protein/albumin ...... th advanced pancreatic cancer.
@en
The C-reactive protein/albumin ...... th advanced pancreatic cancer.
@nl
P2093
P2860
P1433
P1476
The C-reactive protein/albumin ...... th advanced pancreatic cancer.
@en
P2093
P2860
P2888
P304
12525-12533
P356
10.1007/S13277-016-5122-Y
P577
2016-06-25T00:00:00Z